Blood lipid level changed by immunosuppressive drugs in renal transplantation recipients
10.3760/cma.j.issn.1000-6702.2009.12.009
- VernacularTitle:不同免疫抑制剂所致肾移植受者血脂水平变化的比较
- Author:
Zhangxin ZENG
;
Xinxiang YUAN
;
Qinghua WANG
;
Ying WANG
;
Minying TANG
;
Lin WU
;
Jianming TAN
- Publication Type:Journal Article
- Keywords:
Kidney transplantation;
Immunosuppressive agents;
Hyperlipidmia
- From:
Chinese Journal of Urology
2009;30(12):813-815
- CountryChina
- Language:Chinese
-
Abstract:
Objective To compare the effects on blood lipid level by immunosuppressive drugs in renal transplantation recipients. Methods Two hundred and eighty-three renal allograft recipients with tacrolimus(FK506), cyclosporine A(CsA) and rapamycin (SRL) immunosuppressive regimen were reviewed in this study. The variation of whose total cholesterol(TC) and triglyceride(TG) concentration in serum were compared before and after three immunosuppressive regimen. Results There was no significant difference in TC and TG before and after oral FK506 for 93 patients[(4.9± 1. 1) and (1. 4±0. 8)mmol/L vs (4. 9±1.1) and (1.4±1.0)mmol/L, respectively, P>0. 05]. The concentration of TC and TG from 106 patients with CsA[(4. 8±1. 0) and (1. 6±0. 8)mmol/L vs (6. 6±1. 7) and (3. 2±1. 0)mmol/L, respectively] and 29 patients with SRL was higher than those before taking drugs, P<0. 05. The concentration was increased after 12 to 24 weeks generally. The concentration of TC and TG of CsA from FK506 to tacrolimus for 51 patients[(6. 7±1. 1) and (2. 8± 1. 0)mmol/L vs (4. 7±1. 7) and (1. 5±1. l)mmol/L, respectively] were decreased after 12 weeks (P<0. 01). Conclusions Primary factor of dyslipidemia was that CsA and SRL were used for patients post-renal transplantation, which should be regarded. The FK506-based immunosuppressive regimen should be recomended in renal transplantation patients who have a hyperlipidmia.
